VNDA
Vanda Pharmaceuticals Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +0.5% · neue Nettopositionen -5.9% · Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 76 | 0 | 37.76M | $231.07M | +7 | −7 |
| Q1 2026 | 78 | +6 | 33.85M | $233.91M | +14 | −8 |
| Q4 2025 | 72 | -1 | 30.64M | $270.14M | +1 | −2 |
| Q3 2025 | 17 | 0 | 25.97M | $129.59M | n/a | −1 |
| Q2 2025 | 15 | 0 | 24.58M | $116.00M | n/a | n/a |
| Q1 2025 | 12 | 0 | 9.69M | $44.48M | n/a | n/a |
| Q4 2024 | 12 | +1 | 8.66M | $41.48M | +1 | n/a |
| Q3 2024 | 10 | -1 | 7.15M | $33.54M | n/a | −1 |
| Q2 2024 | 11 | n/a | 6.99M | $39.47M | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 8.92M | -5.5% | $44.50M | 0.0% | ▼ Trim | 2 | SEC ↗ ×10 |
| 2 | The Vanguard Group ✦ (passiv) | 3.59M | +0.4% | $17.90M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 3 | Renaissance Technologies ✦ | 3.48M | +0.8% | $17.35M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 4 | Millennium Management ✦ | 3.25M | +4.2% | $16.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 1.39M | -17.7% | $6.95M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (passiv) | 1.27M | +0.4% | $6.34M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 668.47K | +392.5% | $3.34M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 8 | Two Sigma Investments ✦ | 662.30K | +25.7% | $3.30M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 637.50K | n/a | $3.18M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 10 | Marshall Wace ✦ | 581.25K | +23.2% | $2.90M | 0.0% | ▲ Add | 4 | SEC ↗ ×3 |
| 11 | JPMorgan Chase ✦ | 399.79K | n/a | $1.99M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 12 | Goldman Sachs Group ✦ | 339.70K | n/a | $1.70M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 13 | Citadel Advisors ✦ | 263.81K | +78.5% | $1.32M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 14 | Wellington Management ✦ | 189.05K | -35.4% | $943,345 | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 15 | Fidelity (FMR) ✦ | 179.54K | +11.1% | $895,908 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 16 | D. E. Shaw & Co. ✦ | 122.33K | -25.5% | $610,412 | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | T. Rowe Price ✦ | 29.26K | +9.3% | $146,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Norges Bank | $542,800 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 168 Inhaber, 45.91M Anteile, $293.46M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.